2025 HCPCS Code C9753
Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)
TAGS: additional primary guidance imaging intraosseous addition destruction separately vertebral basivertebral| Notice | HCPCS C9753 terminated on December 31, 2021. |
| Short Description | Intraosseous destruct add'l |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 2019 |
| HCPCS Action Effective Date | January 01, 2022 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 2 - Surgery |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9076 - Lisocabtagene car pos t
- C9077 - Inj cabotegravir/rilpivirine
- C9078 - Inj, trilaciclib, 1 mg
- C9079 - Inj, evinacumab-dgnb, 5 mg
- C9080 - Inj, melphalan flufen, 1 mg
- C9081 - Idecabtagene car pos t
- C9082 - Inj dostarlimab-gxly, 100 mg
- C9083 - Inj, amivantamab-vmjw, 10 mg
- C9084 - Loncastuximab-lpyl, 0.1 mg
- C9085 - Inj avalglucosid alfa-ngpt
- C9086 - Inj, anifrolumab-fnia
- C9087 - Inj cyclophosphamd auromedic
- C9088 - Instill, bupivac and meloxic
- C9089 - Bupivacaine implant, 1 mg
- C9090 - Plasminogen, human-tvmh 1 mg
- C9091 - Sirolimus, protein-bound,1mg
- C9092 - Inj., xipere, 1 mg
- C9093 - Inj., susvimo, 0.1 mg
- C9094 - Inj, sutimlimab-jome, 10 mg
- C9095 - Inj, tebentafusp-tebn, 1 mcg